The occurrence of seizures as death nears is most distressing not only to the patient but to the family and caregivers as well. In some instances, these are difficult to manage medically, and the patient dies obtunded by medication. Seizures in this circumstance are due to organ failure, which cause the following:
• Altered homeostasis due to multiorgan failure;
• Electrolyte or other metabolic disturbance;
• Ischemic or hypoxic encephalopathy; or
• Raised blood concentrations of medications due to renal and hepatic failure.
Death due to a chronic illness, such as cancer, is rarely quick. It is a continuous process as the body and brain are unable to cope with hypoxia, malnutrition, electrolyte imbalance, tumor burden, and toxins that are not cleared from the body as hepatic and renal failure occur. Emotion, cognition, thinking, behavior, and autonomic function all slowly deteriorate, and, in most cases, coma ensues before death. Two roads to coma have been identified as death approaches: the high road and the low road. The low road is the more common and is a path of increasing sedation to coma and death. This path does not seem to be traumatic for patients, and the survivors generally recall a peaceful death.
The high road to coma is much more traumatic, often resembling the organic brain syndrome of delirium. Seizures may be one of the symptoms of this syndrome, along with restlessness, confusion, agitation, hallucinations, myoclonic jerks, and, finally, coma. A preterminal delirium can start as many as nine days before death. Over time, the symptoms often become increasingly severe, and the survivors frequently will remember a terrible death even when the symptoms were well-controlled up until the preterminal delirium. 1 In addition to organ failure at the end, other confounding variables may play a role in causing seizures in patients with cancer:
• Direct invasion of the brain or leptomeninges by tumor;
• Cancer-associated vascular disease such as nonbacterial thrombotic endocarditis;
• Opportunistic infection;
• Metabolic abnormalities;
• Chemotherapeutic drugs; or • Paraneoplastic syndromes, including limbic encephalopathy.
An often overlooked etiology of terminal seizures is related to medication withdrawal, especially opioids. Indeed, one study of new onset seizures in intensive care units attributed one-third of these to stopping opioid drugs. Withdrawal of other medication, such as benzodiazepines, barbiturates, and anticonvulsants, can give rise to seizures that generally occur two to four days after sudden withdrawal of the drug. 2 Given this discussion, the article by Baldwin 3 is important in that the author has clearly addressed the issue of identifying those patients who are at risk for seizures using the seizure scale. Unfortunately, some components of this tool require the use of laboratory data, which are often not obtained in hospice patients, and which are not applicable to terminal seizures that may occur de novo. Nonetheless, the seizure scale is useful for raising the awareness of this complication in certain patients, as well as for providing a level of comfort for the nursing staff, as does the availability of the diazepam seizure kit.
